Vaxcell-Bio Therapeutics, Co. Ltd operates pharmaceutical development businesses. The Company develops anti-cancer drugs, cellular drugs, immune drugs, and other medicines. Vaxcell-Bio Therapeutics conducts businesses in South Korea.

Relocation of Corporate Headquarters

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Vaxcell-Bio Therapeutics (323990 KS)

Relocation of Corporate Headquarters

[Revised] Decision on Acquisition of Tangible Assets(Voluntary Disclosure)

Organization of Investor Relations Event

Material Management Information related to Judgment of Investment(ë°ì¤ë£¨í¨-15ì£¼ (Vaxleukin-15 inj) íëª©íê° ë³ê²½ì ì² ì¹ì¸)

Organization of Investor Relations Event

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Relocation of Corporate Headquarters

[Revised] Decision on Acquisition of Tangible Assets(Voluntary Disclosure)

Organization of Investor Relations Event

Material Management Information related to Judgment of Investment(ë°ì¤ë£¨í¨-15ì£¼ (Vaxleukin-15 inj) íëª©íê° ë³ê²½ì ì²­ ì¹ì¸)

Organization of Investor Relations Event

Material Management Information related to Judgment of Investment(ë°ì¤ë£¨í¨-15ì£¼ (Vaxleukin-15 inj) íëª©íê° ë³ê²½ì ì² ì¹ì¸)